Development of health biotechnology in developing countries

Can private-sector players be the prime movers?

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.

Original languageEnglish
Pages (from-to)1589-1601
Number of pages13
JournalBiotechnology Advances
Volume30
Issue number6
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Private Sector
Biotechnology
Developing countries
Developing Countries
Health
Industry
Innovation
Delivery of Health Care
Public-Private Sector Partnerships
Government Agencies
Republic of Korea
Economic Development
Economics
Health Status
Brazil
India
Organizations
Technology
Research

Keywords

  • Economic growth
  • Health biotechnology
  • Health innovation system
  • Innovative developing countries
  • Private sector role
  • Public/private partnership

ASJC Scopus subject areas

  • Biotechnology

Cite this

Development of health biotechnology in developing countries : Can private-sector players be the prime movers? / Abuduxike, Gulifeiya; Syed Junid, Syed Mohamed Al-Junid.

In: Biotechnology Advances, Vol. 30, No. 6, 11.2012, p. 1589-1601.

Research output: Contribution to journalArticle

@article{629630deeb3b48f2830684d4c3c55356,
title = "Development of health biotechnology in developing countries: Can private-sector players be the prime movers?",
abstract = "Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.",
keywords = "Economic growth, Health biotechnology, Health innovation system, Innovative developing countries, Private sector role, Public/private partnership",
author = "Gulifeiya Abuduxike and {Syed Junid}, {Syed Mohamed Al-Junid}",
year = "2012",
month = "11",
doi = "10.1016/j.biotechadv.2012.05.002",
language = "English",
volume = "30",
pages = "1589--1601",
journal = "Biotechnology Advances",
issn = "0734-9750",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Development of health biotechnology in developing countries

T2 - Can private-sector players be the prime movers?

AU - Abuduxike, Gulifeiya

AU - Syed Junid, Syed Mohamed Al-Junid

PY - 2012/11

Y1 - 2012/11

N2 - Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.

AB - Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.

KW - Economic growth

KW - Health biotechnology

KW - Health innovation system

KW - Innovative developing countries

KW - Private sector role

KW - Public/private partnership

UR - http://www.scopus.com/inward/record.url?scp=84867728783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867728783&partnerID=8YFLogxK

U2 - 10.1016/j.biotechadv.2012.05.002

DO - 10.1016/j.biotechadv.2012.05.002

M3 - Article

VL - 30

SP - 1589

EP - 1601

JO - Biotechnology Advances

JF - Biotechnology Advances

SN - 0734-9750

IS - 6

ER -